Skip to main content

Table 1 Recruiting centres opened and ethical approvals

From: Study design for development of novel safety biomarkers of drug-induced liver injury by the translational safety biomarker pipeline (TransBioLine) consortium: a study protocol for a nested case–control study

Centre

Location

Ethical approval

Addenbrooke’s University Hospital, Cambridge University Hospitals NHS Trust Hospital

Cambridge, UK

UK Health Research Authority (Refs.: 15/YH/0294; GM010201; 14/EM/0145)

Hampshire Hospitals NHS Foundation Trust

Basingstoke, UK

Newcastle upon Tyne Hospitals NHS Foundation Trust

Newcastle upon Tyne, UK

Ninewells Hospital, Tayside NHS Trust

Dundee, UK

Nottingham University Hospitals NHS Trust

Nottingham, UK

Queen Alexandra Hospital, Portsmouth Hospitals NHS Trust

Portsmouth, UK

Royal Cornwall Hospitals NHS Trust

Treliske, UK

Royal Free Hospital

London, UK

Royal Sussex County Hospital, Brighton and Sussex University Hospitals NHS Trust

Brighton, UK

University Hospitals Birmingham

Birmingham, UK

University Hospitals Trust Southampton

Southampton, UK

Landspitali University Hospital

Reykjavik, Iceland

Bioethics Committee Iceland (Ref.: 15–104-V1)

Malaga University Hospital

Malaga, Spain

Biomedical Investigation Ethics Committee of Andalucia (Ref.: AND-HEP-2015–01)

Munich University Hospital

Munich, Germany

Ethical Commission of Ludwig Maximilian University of Munich (Project 85–16)

Sahlgrenska University Hospital

Gothenburg, Sweden

Swedish Ethics Review Authority (Ref.: 2022–04078-01)

University Hospital Bern

Bern, Switzerland

Bern Cantonal Ethics Committee for Research (Ref.: 2016–00932)

University Hospital Zurich

Zurich, Switzerland

Zurich Cantonal Ethics Committee (Ref.: 2019–01451)

Pfizer Global Research & Development

Brussels, Belgium

Ethics Committee Erasme Hospital (Ref.: P2019/530)